Becton, Dickinson and Company

Medical Equipment
BDX
$ 249 (0.68)%
Share price
$ 71 bn
Market Cap
$ 87 bn
Enterprise Value

Carbon footprint

5 Ton
GHG emissions per $ 1 mln investment
0.18x the weighted average for S&P 500
FY2020
How is this calculated?
+21%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-5.5%
Proj. YOY change in GHG emissions (Scope 1 + 2)
In line with the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

Becton, Dickinson and Company aims to reduce Scope 1 + 2 by 46% by 2030 from a base year 2019


This target has not been verified as science based according to SBTi
Becton, Dickinson and Company's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Becton, Dickinson and Company's GHG emissions (market-based) (Kt of CO2e)
Becton, Dickinson and Company's Carbon intensity (Tons per 1 USDm)

Becton, Dickinson and Company's carbon footprint

Becton, Dickinson and Company reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 30 September 2020 at 433 Kt (+76/+21% y-o-y). Carbon intensity also skyrocketed to 25 t (+4.6/+22% y-o-y).

Becton, Dickinson and Company's Scope 3 emissions was down at 2,251 Kt (-220 /-8.9% y-o-y). There has been no clear trend lately.

The company is committed to reducing Scope 1 + 2 by 46% by 2030 from a base year 2019, which translates into the estimated reduction of -24 Kt per annum over the period of FY2021 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...
Copyright © 2022 Exerica. All rights reserved.